Ccr5 Δ32 homozygous cord blood allogeneic transplantation in a patient with hiv: A case report

The Lancet HIV

Volumn 2, Issue 6, 2015, Pages e236-e242

  Duarte, Rafael F ^a   Salgado, María ^b   Sánchez Ortega, Isabel ^a   Arnan, Montserrat ^a   Canals, Carmen ^c   Domingo Domenech, Eva ^a   Fernández de Sevilla, Alberto ^a   González Barca, Eva ^a   Morón López, Sara ^b   Nogues, Nuria ^c   Patiño, Beatriz ^a   Puertas, Maria Carmen ^b   Clotet, Bonaventura ^b,d   Petz, Lawrence D ^e   Querol, Sergio ^c   Martinez Picado, Javier ^b,d,f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BANC DE SANG I TEIXITS   (Spain)

^d UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

^e StemCyte   (United States)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; BUSULFAN; CARMUSTINE; CHEMOKINE RECEPTOR CCR5; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; LAMIVUDINE; MELPHALAN; METHYLPREDNISOLONE; NEVIRAPINE; OXALIPLATIN; PREDNISONE; RALTEGRAVIR; RITUXIMAB; TENOFOVIR; THYMOCYTE ANTIBODY; VINCRISTINE; CCR5 PROTEIN, HUMAN;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CASE REPORT; CHIMERA; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; GRAFT VERSUS HOST REACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE FUNCTION TEST; KIDNEY MASS; LARGE CELL LYMPHOMA; LIVER VEIN OBSTRUCTION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THAWING; UMBILICAL CORD BLOOD; VIRAL TROPISM; VIREMIA; CORD BLOOD STEM CELL TRANSPLANTATION; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HOMOZYGOTE; IMMUNOLOGY; TRANSPLANTATION;

ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HOMOZYGOTE; HUMANS; MALE; RECEPTORS, CCR5; TRANSPLANTATION, HOMOLOGOUS;

EID: 84947041117     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00083-1     Document Type: Article

References (30)

1. Hütter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360: 692-98.
2. Allers K, Hütter G, Hofmann J, et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood 2011; 117: 2791-99.
3. Henrich TJ, Hu Z, Li JZ, et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis 2013; 207: 1694-702.
4. Henrich TJ, Hanhauser E, Marty FM, et al. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med 2014; 161: 319-27.
5. Deeks SG, McCune JM. Can HIV be cured with stem cell therapy? Nat Biotechnol 2010; 28: 807-10.
6. Zaia JA, Forman SJ. Transplantation in HIV-infected subjects: is cure possible? Hematology Am Soc Hematol Educ Program 2013; 2013: 389-93.
7. Hütter G, Thiel E. Allogeneic transplantation of CCR5-defi cient progenitor cells in a patient with HIV infection: an update after years and the search for patient no. 2. AIDS 2011; 25: 273-74.
8. Kordelas L, Verheyen J, Esser S. Shift of HIV tropism in stem-cell transplantation with CCR5 delta32 mutation. N Engl J Med 2014; 371: 880-82.
9. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-03.
10. Ruiz-Ferrer M, Barroso N, Antinolo G, Guilar-Reina J. Analysis of CCR5-D32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fl uorescence resonance energy transfer technologies. J Viral Hepat 2004; 11: 319-23.
11. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-83.
12. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the fi rst 25 years and beyond. Blood 2013; 122: 491-98.
13. Gonzalez G, Park S, Chen D, et al. Identifi cation and frequency of CCR5D32/D32 HIV-resistant cord blood units from Houston area hospitals. HIV Med 2011; 12: 481-86.
14. Petz LD, Redei I, Bryson Y, et al. Hematopoietic cell transplantation with cord blood for cure of HIV infections. Biol Blood Marrow Transplant 2013; 19: 393-97.
15. Magro E, Regidor C, Cabrera R, et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Haematologica 2006; 91: 640-48.
16. Sanchez-ortega I, Arnan M, Patiño B, Herrero MJ, Querol S, Duarte RF. Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia. Bone Marrow Transplant 2014; 49: 145-47.
17. Kwon M, Bautista G, Balsalobre P, et al. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant 2014; 20: 2015-22.
18. Alizadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by realtime quantitative polymerase chain reaction. Blood 2002; 99: 4618-25.
19. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-25.
20. Lengauer T, Sander O, Sierra S, Thielen A, Kaiser R. Bioinformatics prediction of HIV coreceptor usage. Nat Biotechnol 2007; 25: 1407-10.
21. Blankson JN, Bailey JR, Thayil S, et al. Isolation and characterization of replication-competent human immunodefi ciency virus type 1 from a subset of elite suppressors. J Virol 2007; 81: 2508-18.
22. Liu TF, Shafer RW. Web resources for HIV type 1 genotypicresistance test interpretation. Clin Infect Dis 2006; 42: 1608-18.
23. Puertas MC, Massanella M, Llibre JM, et al. for the MaraviBoost Collaborative Group. Intensifi cation of a raltegravir-based regimen with maraviroc in early HIV-1 infection. AIDS 2014; 28: 325-34.
24. Salgado M, Swanson MD, Pohlmeyer CW, et al. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. J Virol 2014; 88: 3342-52.
25. Paquette J. U of M researchers conduct world's fi rst cord blood transplant aimed at curing Leukemia and HIV/AIDS. http://www.healthtalk.umn.edu/2013/04/23/u-of-m-researchers-conduct-worldsfirst-cord-blood-transplant-aimed-at-curing-leukemia-and-hivaids/ (accessed May 11, 2015).
26. Kuball J, Kwon M, Wensing A, et al. Single cord blood transplantation combined with an HLA mismatched third party donor for high-risk haematological patients and HIV infection (Abstract O389). Bone Marrow Transplant 2013; 48 (suppl 2): S65-66.
27. Cillo AR, Krishnan S, McMahon DK, Mitsuyasu RT, Para MF, Mellors JW. Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy. PLoS One 2014; 9: e92118.
28. Agrawal L, Lu X, Qingwen J, et al. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodefi ciency virus type 1 in primary CD4+ cells. J Virol 2004; 78: 2277-87.
29. Duarte RF, Labopin M, Badoglio M, et al. Allogeneic transplantation in patients with HIV-infection: a pair matched cohort study by the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 2015; suppl 1: S5-S6 (abstr 007).
30. Sureda A, Bader P, Cesaro S, et al. Indications for allo- and auto-SCT for hematological diseases, solid tumors and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant 2015; published online March 23. DOI:10.1038/bmt.2015.6.